|
1
|
Ettl T, Schwarz-Furlan S, Gosau M and
Reichert TE: Salivary gland carcinomas. Oral Maxillofac Surg.
16:267–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goyal G, Mehdi SA and Ganti AK: Salivary
gland cancers: Biology and systemic therapy. Oncology. 29:773–780.
2015.PubMed/NCBI
|
|
3
|
Zhang L, Li L, Wang Y, Liu Y and Li C: MC3
Mucoepidermoid carcinoma cell line enriched cancer stem-like cells
following chemotherapy. Oncol Lett. 7:1569–1575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kingston DG: Modern natural products drug
discovery and its relevance to biodiversity conservation. J Nat
Prod. 74:496–511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs over the 30 years from 1981 to 2010. J Nat
Prod. 75:311–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung HY, Qian K, Morris-Natschke SL, Hsu
CS and Lee KH: Recent discovery of plant-derived anti-diabetic
natural products. Nat Prod Rep. 29:580–606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tarkang PA, Appiah-Opong R, Ofori MF,
Ayong LS and Nyarko AK: Application of multi-target
phytotherapeutic concept in malaria drug discovery: A systems
biology approach in biomarker identification. Biomark Res.
4:252016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta SC, Kim JH, Prasad S and Aggarwal
BB: Regulation of survival, proliferation, invasion, angiogenesis,
and metastasis of tumor cells through modulation of inflammatory
pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shin JA, Kim JJ, Choi ES, Shim JH, Ryu MH,
Kwon KH, Park HM, Seo JY, Lee SY, Lim DW, et al: In vitro apoptotic
effects of methanol extracts of Dianthus chinensis and Acalypha
australis L. targeting specificity protein 1 in human oral cancer
cells. Head Neck. 35:992–998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin JA, Ryu MH, Kwon KH, Choi B and Cho
SD: Down-regulation of Akt by methanol extracts of Impatiens
balsamina L. promotes apoptosis in human oral squamous cell
carcinoma cell lines. J Oral Pathol Med. 44:420–428. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zlotogorski A, Dayan A, Dayan D, Chaushu
G, Salo T and Vered M: Nutraceuticals as new treatment approaches
for oral cancer: II. Green tea extracts and resveratrol. Oral
Oncol. 49:502–506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramshankar V and Krishnamurthy A:
Chemoprevention of oral cancer: Green tea experience. J Nat Sci
Biol Med. 5:3–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J, Chen H, Zhang L, Wang Q and Lai
MX: Anti-diabetic effect of standardized extract of Potentilla
discolor Bunge and identification of its active components. Drug
Dev Res. 71:127–132. 2010.
|
|
14
|
Zhang L, Yang J, Chen XQ, Zan K, Wen XD,
Chen H, Wang Q and Lai MX: Antidiabetic and antioxidant effects of
extracts from Potentilla discolor Bunge on diabetic rats induced by
high fat diet and streptozotocin. J Ethnopharmacol. 132:518–524.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song C, Huang L, Rong L, Zhou Z, Peng X,
Yu S and Fang N: Anti-hyperglycemic effect of Potentilla discolor
decoction on obese-diabetic (Ob-db) mice and its chemical
composition. Fitoterapia. 83:1474–1483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wen DS, Zhu XL, Guan SM, Wu YM, Yu LL and
Wu JZ: Silencing of CXCR4 inhibits the proliferation, adhesion,
chemotaxis and invasion of salivary gland mucoepidermoid carcinoma
Mc3 cells in vitro. Oral Oncol. 44:545–554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee EJ, Kim J, Lee SA, et al:
Characterization of newly established oral cancer cell lines
derived from six squamous cell carcinoma and two mucoepidermoid
carcinoma cells. Exp Mol Med. 37:379–390. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shankar S, Siddiqui I and Srivastava RK:
Molecular mechanisms of resveratrol
(3,4,5-trihydroxy-trans-stilbene) and its interaction with
TNF-related apoptosis inducing ligand (TRAIL) in
androgen-insensitive prostate cancer cells. Mol Cell Biochem.
304:273–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yeh CC, Hsieh HL, Lee J, Jan YH, Lai TC,
Hong CY, Hsiao M and Kuo MY: Polyethylenimine-mediated PUMA gene
delivery to orthotopic oral cancer: Suppression of tumor growth
through apoptosis induction in situ and prolonged survival. Head
Neck. 33:878–885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang JG, Lu R, Ye XJ, Zhang J, Tan YQ and
Zhou G: Icaritin reduces oral squamous cell carcinoma progression
via the inhibition of STAT3 signaling. Int J Mol Sci. 18(pii):
E1322017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng HY, Cheng YC, Hsu YM, Wu GH, Kuo CC,
Liou JP, Chang JY, Jin SL and Shiah SG: MPT0B098, a microtubule
inhibitor, suppresses JAK2/STAT3 signaling pathway through
modulation of SOCS3 stability in oral squamous cell carcinoma. PLoS
One. 11:e01584402016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brown ME, Bear MD, Rosol TJ, Premanandan
C, Kisseberth WC and London CA: Characterization of STAT3
expression, signaling and inhibition in feline oral squamous cell
carcinoma. BMC Vet Res. 11:2062015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niu G, Wright KL, Ma Y, Wright GM, Huang
M, Irby R, Briggs J, Karras J, Cress WD, Pardoll D, et al: Role of
Stat3 in regulating p53 expression and function. Mol Cell Biol.
25:7432–7440. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hikisz P and Kiliańska ZM: PUMA, a
critical mediator of cell death-one decade on from its discovery.
Cell Mol Biol Lett. 17:646–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chinembiri TN, du Plessis LH, Gerber M,
Hamman JH and du Plessis J: Review of natural compounds for
potential skin cancer treatment. Molecules. 19:11679–11721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mangal M, Sagar P, Singh H, Raghava GP and
Agarwal SM: NPACT: Naturally occurring plant-based anti-cancer
compound-activity-target database. Nucleic Acids Res.
41:D1124–D1129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shin JA, Kwon KH and Cho SD:
AMPK-activated protein kinase activation by Impatiens balsamina L.
is related to apoptosis in HSC-2 human oral cancer cells.
Pharmacogn Mag. 11:136–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu HJ, Shin JA, Lee SO, Kwon KH and Cho
SD: Extracellular signal-regulated kinase inhibition is required
for methanol extract of Smilax china L.-induced apoptosis through
death receptor 5 in human oral mucoepidermoid carcinoma cells. Mol
Med Rep. 9:663–668. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Liu C, Huang RZ, Chen HF, Liao
ZX, Sun JY, Xia XK and Wang FX: Three new
C-27-carboxylated-lupane-triterpenoid derivatives from Potentilla
discolor Bunge and their in vitro antitumor activities. PLoS One.
12:e01755022017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Christodoulou MI, Kontos CK, Halabalaki M,
Skaltsounis AL and Scorilas A: Nature promises new anticancer
agents: Interplay with the apoptosis-related BCL2 gene family.
Anticancer Agents Med Chem. 14:375–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang IH, Shin JA, Kim LH, Kwon KH and Cho
SD: The caspase 3-dependent apoptotic effect of pycnogenol in human
oral squamous cell carcinoma HSC-3 cells. J Clin Biochem Nutr.
58:40–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang S, Zhu Z, Zhang X, Zhang N and Yao Z:
Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
Oncotarget. 8:6102–6113. 2017.PubMed/NCBI
|
|
33
|
Chatwichien J, Basu S, Budina-Kolomets A,
Murphy ME and Winkler JD: PUMA-dependent apoptosis in NSCLC cancer
cells by a dimeric β-carboline. Bioorg Med Chem Lett. 26:4884–4887.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu HJ, Liu L, Fan L, Zhang LN, Fang C,
Zou ZJ, Li JY and Xu W: The BH3-only protein Puma plays an
essential role in p53-mediated apoptosis of chronic lymphocytic
leukemia cells. Leuk Lymphoma. 54:2712–2719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Xing D and Liu L: PUMA promotes
Bax translocation by both directly interacting with Bax and by
competitive binding to Bcl-XL during UV-induced
apoptosis. Mol Biol Cell. 20:3077–3087. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong A, Yang Z, Shen Y, Zhou J and Shen
Q: Transcription factor STAT3 as a novel molecular target for
cancer prevention. Cancers. 6:926–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Al Zaid Siddiquee K and Turkson J: STAT3
as a target for inducing apoptosis in solid and hematological
tumors. Cell Res. 18:254–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mali SB: Review of STAT3 (Signal
transducers and activators of transcription) in head and neck
cancer. Oral Oncol. 51:565–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Leeman-Neill RJ, Seethala RR, Singh SV,
Freilino ML, Bednash JS, Thomas SM, Panahandeh MC, Gooding WE,
Joyce SC, Lingen MW, et al: Inhibition of EGFR-STAT3 signaling with
erlotinib prevents carcinogenesis in a chemically-induced mouse
model of oral squamous cell carcinoma. Cancer Prev Res. 4:230–237.
2011. View Article : Google Scholar
|
|
40
|
Yu HJ, Park C, Kim SJ, Cho NP and Cho SD:
Signal transducer and activators of transcription 3 regulates
cryptotanshinone-induced apoptosis in human mucoepidermoid
carcinoma cells. Pharmacogn Mag. 10 Suppl 3:S622–S629. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu HJ, Shin JA, Jung JY, Nam JS, Hong IS,
Cho NP and Cho SD: Inhibition of myeloid cell leukemia-1:
Association with sorafenib-induced apoptosis in human
mucoepidermoid carcinoma cells and tumor xenograft. Head Neck.
37:1326–1335. 2015. View Article : Google Scholar : PubMed/NCBI
|
